Analysis of the CCL3-L1 gene for association with HIV-1 susceptibility and disease progression
暂无分享,去创建一个
J. Kaldor | G. Stewart | D. Booth | B. Bennetts | J. Guerin | M. Bugeja | Jan Guerin
[1] L. Barcellos,et al. Gene copy number regulates the production of the human chemokine CCL3‐L1 , 2002, European journal of immunology.
[2] H. Ullum,et al. Effects of CCR5- 32, CCR2-64I, and SDF-1 3A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data , 2001, Annals of Internal Medicine.
[3] D. Cook,et al. Absence of Macrophage-Inflammatory Protein-1α Delays Central Nervous System Demyelination in the Presence of an Intact Blood-Brain Barrier1 , 2001, The Journal of Immunology.
[4] M. Burdick,et al. Differential Expression of CC Chemokines and the CCR5 Receptor in the Pancreas Is Associated with Progression to Type I Diabetes1 , 2000, The Journal of Immunology.
[5] J. Kaldor,et al. CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressors , 2000, AIDS.
[6] Y. Nagai,et al. Enhanced anti‐HIV‐1 activity of CC‐chemokine LD78β, a non‐allelic variant of MIP‐1α/LD78α , 1999 .
[7] E. De Clercq,et al. The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine. , 1999, The Journal of clinical investigation.
[8] G. Stewart. Chemokine genes—beating the odds , 1998, Nature Medicine.
[9] H. Ullum,et al. Production of beta-chemokines in human immunodeficiency virus (HIV) infection: evidence that high levels of macrophage inflammatory protein-1beta are associated with a decreased risk of HIV disease progression. , 1998, The Journal of infectious diseases.
[10] L. Chess,et al. Endogenous Production of β-Chemokines by CD4+, but Not CD8+, T-Cell Clones Correlates with the Clinical State of Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Individuals and May Be Responsible for Blocking Infection with NonSyncytium-Inducing HIV-1 In Vitro , 1998, Journal of Virology.
[11] J. Kaldor,et al. Increased frequency of CCR‐5 Δ32 heterozygotes among long‐term non‐progressors with HIV‐1 infection , 1997 .
[12] J J Goedert,et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. , 1997, Science.
[13] A. Lazzarin,et al. Antigen-driven C–C Chemokine-mediated HIV-1 Suppression by CD4+ T Cells from Exposed Uninfected Individuals Expressing the Wild-type CCR-5 Allele , 1997, The Journal of experimental medicine.
[14] O. Turriziani,et al. C-C chemokines, IL-16, and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV infection. , 1997, Journal of immunology.
[15] B. Bennetts,et al. HIV-1 infection in an individual homozygous for the CCR5 deletion allele , 1997, Nature Medicine.
[16] Richard A Koup,et al. Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.
[17] Virginia Litwin,et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 , 1996, Nature.
[18] Steven M. Wolinsky,et al. Relative resistance to HIV–1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high–risk sexual exposures , 1996, Nature Medicine.
[19] J. Sheridan,et al. Requirement of MIP-1 alpha for an inflammatory response to viral infection. , 1995, Science.
[20] M. Nakao,et al. Structures of human genes coding for cytokine LD78 and their expression , 1990, Molecular and cellular biology.
[21] D. Gjerde,et al. Detection of single-nucleotide polymorphisms with the WAVE DNA fragment analysis system. , 1997, Genetic testing.